GL1X · GenesisL1 explorer

Research workbench

Ghgl of varicella-zoster virus in complex with human neutralizing antibodies

Analyse Ghgl of varicella-zoster virus in complex with human neutralizing antibodies in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4XI5
Type
protein
Length
1,274 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Envelope glycoprotein H; Envelope glycoprotein L; Fab-94 light chain; Fab-94 heavy chain
UniProt
Q775J3, Q9J3N1
Ligands
NAG, BMA, MAN
Pockets
20 · best druggability 0.71

Structure

x-ray diffraction · 4 distinct chains · 23% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEnvelope glycoprotein Hprotein72834% helix, 20% strandQ775J3
BEnvelope glycoprotein Lprotein13227% helix, 14% strandQ9J3N1
CFab-94 light chainprotein2063% helix, 41% strand—
DFab-94 heavy chainprotein2080% helix, 45% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 5 copies · chains A, B
  • BMA · beta-D-mannopyranose · sugar
  • MAN · alpha-D-mannopyranose · sugar · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13680.710.8341empty
24240.680.8042empty
32690.600.7936empty
42270.570.7935empty
52880.570.7735empty

Interfaces

6 interfaces between chains.

  • A–B · 3545 Ų buried · 36 hydrogen bonds · protein-protein
  • C–D · 2076 Ų buried · 11 hydrogen bonds · protein-protein
  • A–D · 513 Ų buried · 4 hydrogen bonds · protein-protein
  • B–D · 253 Ų buried · 6 hydrogen bonds · protein-protein
  • A–C · 144 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 9 disulfide, 4 glycan (disulfide, N-glycosylation).

Compared structures

  • 4XI5 · gHgL of varicella-zoster virus in complex with human neutralizing antibodies · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.